jump to content

Celtic Advanced Life Science Innovation Network

Search the website
Image: Jellagen Pty

Jellagen Pty

Ovarian cancer, the leading cause of cancer-related deaths in women, is a disease with high morbidity and mortality, and limited treatment options. A promising new therapy, involving stem cells, is under development but requires more relevant culture models to be able to translate basic research into clinical applications. Partners: Jellagen Pty Ltd, Swansea University & National University of Ireland, Galway.

Read More Span

Funders